"Pharmacology Research Institute (PRI) is one of the premier independent clinical research centers in Los Alamitos, CA. We specialize in clinical research studies involving paid volunteers. Want to participate in a clinical trial? Check out our website to view our current studies and see if you may qualify for a trial. Clinical trials allow medical researchers to evaluate drug effectiveness and safety in a controlled environment. We are dedicated to conducting safe and successful studies. Past participants often return to participate in more studies because they enjoyed their experience."

During the past decade, Pharmacology Research Institute conducted 65 clinical trials. In the 10-year time frame, 65 clinical trials started and 52 clinical trials were completed, i.e. on average, 80% percent of trials that started reached the finish line to date. In the past 5 years, 28 clinical trials started and 36 clinical trials were completed. i.e. 128.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Pharmacology Research Institute" #1 sponsor was "Pfizer" with 14 trials, followed by "Eli Lilly and Company" with 11 trials sponsored, "Cephalon" with 8 trials sponsored, "Shire" with 6 trials sponsored and "Sunovion" with 6 trials sponsored. Other sponsors include 63 different institutions and companies that sponsored additional 40 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Pharmacology Research Institute" #1 collaborator was "Pfizer" with 4 trials as a collaborator, "CoLucid Pharmaceuticals" with 2 trials as a collaborator, "GlaxoSmithKline" with 1 trials as a collaborator, "JANSSEN Alzheimer Immunotherapy Research & Development, LLC" with 1 trials as a collaborator and "University of Michigan" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Pharmacology Research Institute" are "Alzheimer's Disease" (16 trials), "Migraine" (10 trials), "Alzheimer Disease" (9 trials), "Major Depressive Disorder" (9 trials) and "Depressive Disorder, Major" (8 trials). Many other conditions were trialed in "Pharmacology Research Institute" in a lesser frequency.

Most popular intervention types in "Pharmacology Research Institute" are "Drug" (108 trials), "Other" (6 trials), "Behavioral" (2 trials), "Biological" (2 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (48 trials), "Rimegepant" (5 trials), "placebo" (5 trials), "Dasotraline" (4 trials) and "Gabitril" (4 trials). Other intervention names were less common.

The vast majority of trials in "Pharmacology Research Institute" are 112 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Pharmacology Research Institute". undefined are not yet recruiting, 9 are recruiting, 6 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 80 completed trials in Pharmacology Research Institute, 1 suspended trials, and 14 terminated clinical trials to date.

Out of the total trials that were conducted in Pharmacology Research Institute, 0 "Phase 1" clinical trials were conducted, 37 "Phase 2" clinical trials and 70 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 7 trials, and there were also 3 trials that are defined as “Not Applicable".

Pharmacology Research Institute has several departments that took part in Clinical trials: "Nader Pharmacology Research Institute" - 2 trials